Your gut may be making a molecule that raises Alzheimer’s risk

Automatically curated summary from ScienceDaily — Mind & Brain.

According to a report published by ScienceDaily, scientists have linked a gut bacterial compound known as ImP to an elevated risk of Alzheimer’s disease. The compound is associated with harmful protein buildup in the brain and faster cognitive decline. This finding highlights the potential that reducing blood levels of ImP could eventually help prevent or slow dementia progression. However, this relies on a brief excerpt, so further details regarding methodology, trial phases, and mechanisms remain unspecified.

Context and limitations

The claim that reducing ImP in the blood could slow or prevent dementia is a preliminary possibility requiring further research and clinical verification. Additionally, the excerpt does not provide details on the study's methodology or sample size.